Time for new recommendations on cotrimoxazole prophylaxis for HIV-exposed infants in developing countries?

Bull World Health Organ. 2010 Dec 1;88(12):949-50. doi: 10.2471/BLT.10.076422.

Authors

Anna Coutsoudis¹, Hoosen M Coovadia, Gurpreet Kindra

Affiliation

¹ Department of Paediatrics and Child Health, University of KwaZulu-Natal, Private Bag 7, Congelia, 4013, South Africa. [email protected]

No abstract available

MeSH terms

Anti-Infective Agents / adverse effects
Anti-Infective Agents / therapeutic use*
Clinical Protocols*
Developing Countries*
HIV Infections / prevention & control
HIV Infections / transmission*
Humans
Infant
Infant, Newborn
Infectious Disease Transmission, Vertical*
Pneumocystis carinii / drug effects
Pneumonia, Pneumocystis / prevention & control
Trimethoprim, Sulfamethoxazole Drug Combination / adverse effects
Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use*

Substances

Anti-Infective Agents
Trimethoprim, Sulfamethoxazole Drug Combination